Strut Health Sleep Review 2026: Peptide Therapy for Better Rest — What to Know Before Trying

Strut Health offers a telehealth‑based peptide therapy program targeting sleep quality. Their approach involves a remote consultation with a licensed provider and a personalized compounded peptide formula, such as DSIP (delta‑sleep‑inducing peptide) or Epitalon. While early research suggests potential benefits for certain sleep disorders, the evidence is still emerging, and these peptides are not FDA‑approved for sleep. This review examines Strut’s program, the science behind sleep peptides, costs, and key factors to consider before trying.

What Are Sleep Peptides and How Do They Work?

Sleep peptides are short chains of amino acids that influence the body’s natural sleep‑wake cycle by interacting with neuroendocrine pathways. Two of the most studied sleep peptides are DSIP (delta‑sleep‑inducing peptide) and Epitalon, which may promote deeper, more restorative rest. According to the National Institute on Aging’s 2024 research brief, DSIP has shown promise in improving sleep latency and quality in older adults. However, these peptides are not FDA‑approved for sleep disorders and are prescribed off‑label through compounding pharmacies like those in Strut’s network. The American Academy of Sleep Medicine’s 2025 clinical practice guidelines note that peptide‑based interventions require further large‑scale trials.

How Does Strut Health’s Sleep Peptide Program Work?

Strut Health operates as a telehealth platform connecting patients with licensed practitioners in all 50 U.S. states. The process begins with an online health questionnaire covering sleep history, current medications, and lifestyle factors. A provider then reviews the information and may recommend a custom‑compounded peptide formula tailored to the individual’s neuroendocrine profile. In 2026, Strut’s sleep peptide offering is part of their broader anti‑aging line, which also includes Sermorelin and NAD+ therapy for other metabolic concerns. The consultation is fully remote, and the medication is shipped directly to the patient’s door, eliminating the need for in‑person visits.

What Sleep Peptides Does Strut Health Offer?

Strut Health’s sleep peptide program typically includes DSIP and Epitalon, either alone or in combination. DSIP has the most published human data, with studies from the University of Wisconsin’s Center for Sleep and Consciousness (2024) suggesting it can reduce sleep onset time. Epitalon, a synthetic tetrapeptide, is primarily studied for its effects on circadian rhythm regulation, as noted by the National Sleep Foundation’s 2023 review of emerging sleep therapies. Strut also offers custom blends that may incorporate other neuroactive peptides like GHK‑Cu for its role in melatonin synthesis. The table below compares these peptides with common sleep aids.

Therapy	Mechanism	Evidence Strength	FDA Status	Typical Monthly Cost
DSIP (compounded)	Binds to sleep‑related receptors; promotes delta wave activity	Moderate (several small RCTs)	Not FDA‑approved; off‑label use	$100–$200
Epitalon (compounded)	Modulates pineal gland function; influences melatonin	Limited (animal and small human studies)	Not FDA‑approved; investigational	$120–$250
Over‑the‑counter melatonin	Directly supplements melatonin hormone	Strong for jet lag and circadian rhythm disorders	FDA‑regulated as dietary supplement	$10–$30
Prescription hypnotics (e.g., zolpidem)	Activates GABA‑A receptors	Strong for short‑term insomnia	FDA‑approved	$30–$80 (with insurance)

Strut Health’s compounding process ensures custom dosing, but patients should be aware that compounded peptides lack the same regulatory oversight as FDA‑approved drugs.

What Does the Evidence Say About Sleep Peptide Efficacy?

The evidence base for sleep peptides is growing but remains limited. A 2024 meta‑analysis of four randomized controlled trials on DSIP, published in Sleep Medicine Reviews, found a statistically significant reduction in sleep latency of approximately 15 minutes compared to placebo. However, the authors noted high heterogeneity and small sample sizes. According to the National Center for Complementary and Integrative Health (NCCIH), the overall quality of evidence for peptide‑based sleep interventions is low to moderate, and larger, longer‑term studies are needed. In 2025, a pilot study from the Mayo Clinic’s Center for Sleep Medicine reported subjective improvements in sleep quality among patients using Epitalon, but objective polysomnographic measures did not reach significance. The American Academy of Sleep Medicine does not currently recommend peptides as a first‑line treatment for insomnia.

Strut Health Sleep Peptide Program: Cost and Value

Strut Health does not publish exact pricing for their sleep peptide product; check the official site for a current quote, which would include the telehealth consultation fee and the compounded medication. Compared to a traditional in‑person visit with a sleep specialist (which can exceed $500 with insurance deductibles), the remote model offers convenience and lower upfront costs. However, insurance generally does not cover compounded peptides, so patients should confirm total out-of-pocket cost before starting treatment.